Challenges in Treatment of Patients With Non-Classic Congenital Adrenal Hyperplasia

December 2022 in “ Frontiers in Endocrinology ”

Bas P H Adriaansen, Mariska A M Schröder, P.N. Span, Fred C.G.J. Sweep, Antonius E. van Herwaarden, Hedi L Claahsen–van der Grinten

non-classic congenital adrenal hyperplasia NCCAH androgen glucocorticoid adrenal androgen iatrogenic adrenal insufficiency premature pubarche acne irregular menstruation androgens glucocorticoids

Studysummary This review discusses various treatment options for non-classic congenital adrenal hyperplasia due to 21α-hydroxylase and 11β-hydroxylase deficiencies without providing new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on frontiersin.org →

Discuss this study in the Community →

Research cited in this study

16 / 16 results

research Congenital Adrenal Hyperplasia: Current Insights in Pathophysiology, Diagnostics, and Management

157 citations , May 2021 in “Endocrine Reviews”

This review discusses recent advancements in understanding and managing congenital adrenal hyperplasia, including improvements in screening, diagnostics, and potential genetic and cell-based treatments, but reports no new clinical findings.

research Spironolactone in Dermatology: Uses in Acne and Beyond

8 citations , August 2020 in “Clinical and Experimental Dermatology”

In this review, spironolactone is highlighted for its emerging use in dermatology, particularly for treating androgen-mediated conditions like acne and hirsutism in susceptible females, though it requires careful monitoring for potential adverse effects.

research Laser Treatment in Hirsutism: An Update

16 citations , April 2020 in “Dermatology practical & conceptual”

This article reviews the use of laser and light-based devices for hair removal, highlighting their effectiveness in significantly reducing hair growth in individuals with fair skin and dark hair, and suggests that photoepilation offers advantages over traditional hair removal methods.

research Safety of 5α-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies

22 citations , November 2018 in “Breast Cancer Research and Treatment”

In this review, researchers found no evidence of interactions between 5α-reductase inhibitors or spironolactone and endocrine therapies for breast cancer, with no consistent changes in estrogen levels or increased breast cancer risk associated with spironolactone usage.

research Androgens in Women: Hormone-Modulating Therapies for Androgen-Mediated Cutaneous Disorders

34 citations , October 2018 in “Journal of The American Academy of Dermatology”

This review discusses hormone-modulating therapies for androgen-mediated cutaneous disorders in women but reports no new clinical results and highlights the need for more rigorous studies.

Non-Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Revisited: An Update with a Special Focus on Adolescent and Adult Women

research Non-Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Revisited: An Update with a Special Focus on Adolescent and Adult Women

117 citations , May 2017 in “Human Reproduction Update”

This review examines the epidemiology, pathophysiology, diagnosis, and management strategies for non-classic congenital hyperplasia due to 21-hydroxylase deficiency, and provides evidence-based recommendations for its treatment and genetic counseling.

research Adverse Effects and Safety of 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review

32 citations , July 2016 in “PubMed”

This review discusses the adverse events associated with 5-alpha reductase inhibitors, finding them generally well-tolerated but noting potential risks like sexual side effects and psychological effects in men, and sparse data on use in women.

research Is Hormonal Treatment Still an Option in Acne Today?

31 citations , June 2015 in “British Journal of Dermatology”

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

research Management of Congenital Adrenal Hyperplasia During Pregnancy

29 citations , December 2012 in “Current Opinion in Endocrinology, Diabetes and Obesity”

This review discusses factors affecting fertility in both men and women with congenital adrenal hyperplasia and emphasizes individualized preconception management but reports no new clinical results.

research Hepatotoxicity with Low- and Ultralow-Dose Flutamide: A Surveillance Study on 203 Hyperandrogenic Young Females

29 citations , July 2012 in “Fertility and Sterility”

This study observed that hepatotoxicity is a rare but possible event in hyperandrogenic young females treated with low- and ultralow-dose flutamide, regardless of dose or oral contraceptive use.

research Recommendations for Treatment of Nonclassic Congenital Adrenal Hyperplasia: An Update

56 citations , December 2011 in “Steroids”

This review discusses the genetics and variable phenotypic expression of nonclassic congenital adrenal hyperplasia, and reports no new clinical results; the authors call for further research on long-term health impacts and treatment strategies.

research Phenotypic Profiling of Parents With Cryptic Nonclassic Congenital Adrenal Hyperplasia: Findings in 145 Unrelated Families

62 citations , March 2011 in “European journal of endocrinology”

This study found that parents identified with cryptic NCCAH through genetic testing are mostly asymptomatic but may experience temporary female infertility and require glucocorticoid stress coverage in specific circumstances.

A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia Among Women Presenting with Hyperandrogenic Symptoms and Signs

research A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia Among Women Presenting with Hyperandrogenic Symptoms and Signs

150 citations , November 2007 in “The Journal of Clinical Endocrinology and Metabolism”

This study determined that nonclassical congenital adrenal hyperplasia has a 2.2% prevalence among hyperandrogenic women in Spain, with basal serum 17-hydroxyprogesterone showing excellent diagnostic performance.

research A Randomized Bilateral Vehicle-Controlled Study of Eflornithine Cream Combined with Laser Treatment Versus Laser Treatment Alone for Facial Hirsutism in Women

125 citations , February 2007 in “Journal of the American Academy of Dermatology”

This study found that adding topical eflornithine to laser hair removal significantly improved the reduction of unwanted facial hair in women over a 6-month period, compared to laser treatment alone.

research Inhibition of Skin 5α-Reductase by Oral Contraceptive Progestins In Vitro

78 citations , January 2000 in “Gynecological Endocrinology”

This study found that the progestins norgestimate and dienogest may help treat clinical hyperandrogeny in women by inhibiting skin 5 alpha-reductase activity with minimal androgenic potential.

research The Effect of Spironolactone on Genital Skin 5α-Reductase Activity

50 citations , August 1985 in “Journal of steroid biochemistry/Journal of Steroid Biochemistry”

This study found that spironolactone directly inhibits 5 alpha-reductase activity in hirsute women, resulting in decreased conversion of testosterone to dihydrotestosterone, which may contribute to its therapeutic effects.